Acumen Stock Based Compensation from 2010 to 2026

ABOS Stock  USD 2.51  0.12  5.02%   
Acumen Pharmaceuticals Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2026. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2020-03-31
Previous Quarter
2.5 M
Current Value
2.5 M
Quarterly Volatility
982.8 K
 
Covid
 
Interest Hikes
Check Acumen Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acumen Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 12.4 M, Interest Income of 17.3 M or Depreciation And Amortization of 152.2 K, as well as many indicators such as Price To Sales Ratio of 296, Dividend Yield of 0.0 or PTB Ratio of 0.54. Acumen financial statements analysis is a perfect complement when working with Acumen Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Acumen Stock
Check out the analysis of Acumen Pharmaceuticals Correlation against competitors.
For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.
The evolution of Stock Based Compensation for Acumen Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Acumen Pharmaceuticals compares to historical norms and industry peers.

Latest Acumen Pharmaceuticals' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Acumen Pharmaceuticals over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Acumen Pharmaceuticals' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acumen Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Acumen Stock Based Compensation Regression Statistics

Arithmetic Mean2,610,089
Geometric Mean575,929
Coefficient Of Variation161.26
Mean Deviation3,353,537
Median174,000
Standard Deviation4,209,030
Sample Variance17.7T
Range11.5M
R-Value0.79
Mean Square Error7.1T
R-Squared0.62
Significance0.0002
Slope657,840
Total Sum of Squares283.5T

Acumen Stock Based Compensation History

202611.6 M
202511.1 M
20249.6 M
20236.1 M
20223.1 M
2021922 K
2020154 K

Other Fundumenentals of Acumen Pharmaceuticals

Acumen Pharmaceuticals Stock Based Compensation component correlations

0.990.96-0.46-0.920.710.670.470.991.00.990.580.480.80.870.53-0.6
0.990.97-0.54-0.880.650.590.331.00.990.990.530.470.720.830.46-0.52
0.960.97-0.5-0.920.770.670.320.960.970.960.630.290.720.810.58-0.63
-0.46-0.54-0.50.190.050.230.27-0.49-0.53-0.570.1-0.050.15-0.230.18-0.21
-0.92-0.88-0.920.19-0.91-0.87-0.58-0.9-0.89-0.87-0.71-0.28-0.89-0.91-0.70.84
0.710.650.770.05-0.910.950.630.680.680.640.850.00.850.760.88-0.96
0.670.590.670.23-0.870.950.770.630.630.580.830.190.920.730.85-0.93
0.470.330.320.27-0.580.630.770.380.410.360.570.240.760.560.6-0.69
0.991.00.96-0.49-0.90.680.630.380.990.990.550.490.760.850.5-0.56
1.00.990.97-0.53-0.890.680.630.410.991.00.550.470.740.850.49-0.55
0.990.990.96-0.57-0.870.640.580.360.991.00.510.490.70.820.45-0.49
0.580.530.630.1-0.710.850.830.570.550.550.510.020.790.660.99-0.81
0.480.470.29-0.05-0.280.00.190.240.490.470.490.020.420.39-0.080.1
0.80.720.720.15-0.890.850.920.760.760.740.70.790.420.850.79-0.85
0.870.830.81-0.23-0.910.760.730.560.850.850.820.660.390.850.61-0.69
0.530.460.580.18-0.70.880.850.60.50.490.450.99-0.080.790.61-0.87
-0.6-0.52-0.63-0.210.84-0.96-0.93-0.69-0.56-0.55-0.49-0.810.1-0.85-0.69-0.87
Click cells to compare fundamentals

About Acumen Pharmaceuticals Financial Statements

Acumen Pharmaceuticals shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Acumen Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Acumen Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Acumen Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation11.1 M11.6 M
Stock Based Compensation To Revenue 0.10  0.08 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Acumen Stock Analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.